Johnson and Johnson Medical Saudi Arabia Limited, a provider of high-tech medical and surgical equipment, has announced the establishment of its direct operations in the Kingdom. This comes as a strategic move to bring customers closer to the Johnson and Johnson legacy, facilitating a more streamlined experience.
A significant milestone, this move reflects the company’s continued investment in the future of Saudi healthcare and its commitment toward enhancing medical interventions and improving clinical outcomes.
The new direct model will give J&J MedTech greater control over the customer experience, ultimately translating into better patient outcomes. Key benefits of the newly established direct model include consistent service quality, centralized product source adhering to Johnson and Johnson’s quality standards, faster response times to customer concerns, improved tracking and product visibility, and increased scope of collaborations, among others. This milestone reflects Johnson and Johnson’s relentless commitment to providing communities across the world with the best in healthcare. The go-to-market model transformation is a pivotal moment in the company’s history.
Marzena Kulis, managing director of J&J MedTech for Middle East and Africa, said: “We remain deeply vested in Saudi Arabia and in contributing to Vision 2030 to support in developing the healthcare sector, driving economic growth, nurturing local talent, and fostering innovation. As an entity, Johnson and Johnson has been present in Saudi Arabia for nearly 40 years, putting the needs of patients, families, physicians, and nurses first, and functioning as advocates for the health of the Saudi community. As we transition into this new direct model, I truly believe that our esteemed partners will have fewer obstacles in providing the best care for their patients.”
Furthermore, aligned with J&J MedTech KSA’s mandate to support the government’s Saudi nationalization scheme or Nitaqat, the GTM model transformation has created multiple job opportunities for Saudi nationals. In addition to this, Johnson and Johnson supported 345 direct jobs in Saudi Arabia in 2022, primarily in the fields of marketing and sales, and for every direct job supported by Johnson and Johnson in the Kingdom, an additional 2.5 jobs are supported in the country.
Trad Al-Khelaiwi, general manager of J&J MedTech KSA, added: “As a company that is dedicated to fostering local talent, our direct operations are also aimed at creating more opportunities within the Kingdom and supporting the government’s Saudization efforts. In fact, since the start of the project, we’ve made 76 new hires — with our priority and majority being Saudi nationals. I have no doubt that this transformative shift will bring our customers closer to Johnson and Johnson’s exceptional quality standards and develop the local healthcare market with international know-how. We will continue to work toward the benefit of healthcare in Saudi Arabia and our communities at large.”
Commenting on the strategic move, Peter Lane, transformation director at J&J MedTech, said: “By taking this bold step, we are not only embracing the health goals of Vision 2030 and aligning with the Health Sector Transformation Program, but also spotlighting the immense potential of local talent in driving innovation and progress. This strategic move exemplifies our commitment to enriching the healthcare sector in the Kingdom, fostering a global collaborative approach that synergizes with the nation’s aspirations for a healthier and prosperous future.”
